vs
ICU MEDICAL INC（ICUI）与Stitch Fix, Inc.（SFIX）财务数据对比。点击上方公司名可切换其他公司
ICU MEDICAL INC的季度营收约是Stitch Fix, Inc.的1.6倍（$540.7M vs $342.1M），Stitch Fix, Inc.净利率更高（-1.9% vs -2.9%，领先1.1%），Stitch Fix, Inc.同比增速更快（7.3% vs -14.1%），ICU MEDICAL INC自由现金流更多（$36.0M vs $5.6M），过去两年Stitch Fix, Inc.的营收复合增速更高（1.8% vs -2.3%）
ICU医疗是总部位于美国加利福尼亚州圣克莱门特的医疗科技企业，专注于研发预防血流感染、保护医护人员免受传染病或危险药物侵害的医疗产品，产品线覆盖静脉治疗用品、输液泵、无针血管通路设备、定制输液套装、危险药物密闭处理系统、传感导管以及无针封闭式血液采样系统等。
Stitch Fix是美国的在线个人造型服务平台，依托推荐算法与数据科学技术，根据顾客的身形尺寸、预算和风格偏好推送个性化服饰单品。该公司创立于2011年，2017年完成首次公开募股，目前总部位于旧金山。
ICUI vs SFIX — 直观对比
营收规模更大
ICUI
是对方的1.6倍
$342.1M
营收增速更快
SFIX
高出21.5%
-14.1%
净利率更高
SFIX
高出1.1%
-2.9%
自由现金流更多
ICUI
多$30.4M
$5.6M
两年增速更快
SFIX
近两年复合增速
-2.3%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $540.7M | $342.1M |
| 净利润 | $-15.7M | $-6.4M |
| 毛利率 | 37.5% | 43.6% |
| 营业利润率 | 1.0% | -2.5% |
| 净利率 | -2.9% | -1.9% |
| 营收同比 | -14.1% | 7.3% |
| 净利润同比 | 34.0% | -1.7% |
| 每股收益（稀释后） | $-0.63 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ICUISFIX
| Q4 25 | $540.7M | $342.1M | ||
| Q3 25 | $537.0M | $311.2M | ||
| Q2 25 | $548.9M | $325.0M | ||
| Q1 25 | $604.7M | $312.1M | ||
| Q4 24 | $629.8M | $318.8M | ||
| Q3 24 | $589.1M | $319.6M | ||
| Q2 24 | $596.5M | $322.7M | ||
| Q1 24 | $566.7M | $330.4M |
净利润ICUISFIX
| Q4 25 | $-15.7M | $-6.4M | ||
| Q3 25 | $-3.4M | $-8.6M | ||
| Q2 25 | $35.3M | $-7.4M | ||
| Q1 25 | $-15.5M | $-6.5M | ||
| Q4 24 | $-23.8M | $-6.3M | ||
| Q3 24 | $-33.0M | $-36.5M | ||
| Q2 24 | $-21.4M | $-21.3M | ||
| Q1 24 | $-39.5M | $-35.5M |
毛利率ICUISFIX
| Q4 25 | 37.5% | 43.6% | ||
| Q3 25 | 37.4% | 43.6% | ||
| Q2 25 | 37.9% | 44.2% | ||
| Q1 25 | 34.7% | 44.5% | ||
| Q4 24 | 36.1% | 45.4% | ||
| Q3 24 | 34.8% | 44.6% | ||
| Q2 24 | 34.8% | 45.5% | ||
| Q1 24 | 32.7% | 43.4% |
营业利润率ICUISFIX
| Q4 25 | 1.0% | -2.5% | ||
| Q3 25 | 2.6% | -3.6% | ||
| Q2 25 | 1.9% | -3.0% | ||
| Q1 25 | 2.1% | -2.9% | ||
| Q4 24 | 6.0% | -2.8% | ||
| Q3 24 | 1.4% | -13.1% | ||
| Q2 24 | 1.3% | -7.7% | ||
| Q1 24 | -1.9% | -11.5% |
净利率ICUISFIX
| Q4 25 | -2.9% | -1.9% | ||
| Q3 25 | -0.6% | -2.8% | ||
| Q2 25 | 6.4% | -2.3% | ||
| Q1 25 | -2.6% | -2.1% | ||
| Q4 24 | -3.8% | -2.0% | ||
| Q3 24 | -5.6% | -11.4% | ||
| Q2 24 | -3.6% | -6.6% | ||
| Q1 24 | -7.0% | -10.8% |
每股收益（稀释后）ICUISFIX
| Q4 25 | $-0.63 | $-0.05 | ||
| Q3 25 | $-0.14 | $-0.06 | ||
| Q2 25 | $1.43 | $-0.06 | ||
| Q1 25 | $-0.63 | $-0.05 | ||
| Q4 24 | $-0.97 | $-0.05 | ||
| Q3 24 | $-1.35 | $-0.29 | ||
| Q2 24 | $-0.88 | $-0.18 | ||
| Q1 24 | $-1.63 | $-0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $244.2M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $2.1B | $204.1M |
| 总资产 | $4.1B | $530.7M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ICUISFIX
| Q4 25 | — | $244.2M | ||
| Q3 25 | — | $234.9M | ||
| Q2 25 | — | $234.2M | ||
| Q1 25 | — | $219.1M | ||
| Q4 24 | $308.6M | $253.3M | ||
| Q3 24 | $312.5M | $247.0M | ||
| Q2 24 | $302.6M | $244.5M | ||
| Q1 24 | $251.4M | $229.8M |
股东权益ICUISFIX
| Q4 25 | $2.1B | $204.1M | ||
| Q3 25 | $2.1B | $203.0M | ||
| Q2 25 | $2.1B | $200.4M | ||
| Q1 25 | $2.0B | $197.8M | ||
| Q4 24 | $2.0B | $190.5M | ||
| Q3 24 | $2.0B | $187.0M | ||
| Q2 24 | $2.0B | $208.9M | ||
| Q1 24 | $2.1B | $213.3M |
总资产ICUISFIX
| Q4 25 | $4.1B | $530.7M | ||
| Q3 25 | $4.1B | $480.6M | ||
| Q2 25 | $4.1B | $484.7M | ||
| Q1 25 | $4.2B | $472.6M | ||
| Q4 24 | $4.2B | $507.1M | ||
| Q3 24 | $4.3B | $486.9M | ||
| Q2 24 | $4.3B | $537.0M | ||
| Q1 24 | $4.3B | $538.3M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $60.6M | $10.9M |
| 自由现金流经营现金流 - 资本支出 | $36.0M | $5.6M |
| 自由现金流率自由现金流/营收 | 6.6% | 1.6% |
| 资本支出强度资本支出/营收 | 4.6% | 1.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $91.8M | $4.9M |
8季度趋势，按日历期对齐
经营现金流ICUISFIX
| Q4 25 | $60.6M | $10.9M | ||
| Q3 25 | $56.7M | $7.0M | ||
| Q2 25 | $11.2M | $20.5M | ||
| Q1 25 | $51.3M | $-16.2M | ||
| Q4 24 | $40.2M | $14.3M | ||
| Q3 24 | $36.1M | $8.2M | ||
| Q2 24 | $82.0M | $21.7M | ||
| Q1 24 | $45.8M | $-22.3M |
自由现金流ICUISFIX
| Q4 25 | $36.0M | $5.6M | ||
| Q3 25 | $27.6M | $2.8M | ||
| Q2 25 | $-8.5M | $16.0M | ||
| Q1 25 | $36.7M | $-19.4M | ||
| Q4 24 | $16.1M | $9.9M | ||
| Q3 24 | $16.2M | $4.5M | ||
| Q2 24 | $62.5M | $18.9M | ||
| Q1 24 | $29.9M | $-26.1M |
自由现金流率ICUISFIX
| Q4 25 | 6.6% | 1.6% | ||
| Q3 25 | 5.1% | 0.9% | ||
| Q2 25 | -1.5% | 4.9% | ||
| Q1 25 | 6.1% | -6.2% | ||
| Q4 24 | 2.6% | 3.1% | ||
| Q3 24 | 2.7% | 1.4% | ||
| Q2 24 | 10.5% | 5.9% | ||
| Q1 24 | 5.3% | -7.9% |
资本支出强度ICUISFIX
| Q4 25 | 4.6% | 1.6% | ||
| Q3 25 | 5.4% | 1.4% | ||
| Q2 25 | 3.6% | 1.4% | ||
| Q1 25 | 2.4% | 1.0% | ||
| Q4 24 | 3.8% | 1.4% | ||
| Q3 24 | 3.4% | 1.2% | ||
| Q2 24 | 3.3% | 0.9% | ||
| Q1 24 | 2.8% | 1.1% |
现金转化率ICUISFIX
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 0.32× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ICUI
| Infusion Consumables | $284.7M | 53% |
| Infusion Systems | $176.3M | 33% |
| Vital Care | $79.7M | 15% |
SFIX
暂无分部数据
